DePuy DTC pays off
This article was originally published in The Gray Sheet
Executive SummaryJ&J ortho unit posts Q1 sales of $993 mil., up 18% versus the prior-year period. Direct-to-consumer ads contributed to 21% growth in joint reconstruction sales, which outstripped market growth estimates of 12%, VP-Investor Relations Helen Short said...
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.